Stock and Flow of Haemodialysis Patients Australia 2003 - 2007 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 7536 Patients 2003 2004 2005 2006 2007

Stock and Flow of Haemodialysis Patients New Zealand 2003 - 2007 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1323 Patients 2003 2004 2005 2006 2007

Age of New Haemodialysis Patients 2007 Australia No. Pats. 9 45 94 184 303 418 479 385 47

Age of Current Haemodialysis Patients Australia 31-Dec-2007 No. Pats. 5 98 305 731 1201 1595 1804 1582 215

Age of New Haemodialysis Patients 2007 New Zealand No. Pats. 3 20 16 45 63 95 89 38 4

Age of Current Haemodialysis Patients New Zealand 31-Dec-2007 No. Pats. 3 38 79 162 261 360 299 108 13

Distribution of Blood Flow Rates Number of Patients Australia

Distribution of Blood Flow Rates Number of Patients New Zealand

Haemodialysis Frequency (Per Week) December 2005 - 2007 Australia New Zealand

Haemodialysis Session Length (Hours) December 2005 - 2007 Australia New Zealand

Haemodialysis Duration (Hours per Week) December 2005 - 2007 Australia New Zealand

Percentage of Patients Dialysing Five or More Days per Week .5 1 1.5 2 2.5 3 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing Five or More Days per Week

Percentage of Patients Dialysing Three Days per Week 45 50 55 60 65 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing Three Days per Week Dialysing 4.5 Hours per Session or Longer

Percentage of Patients Dialysing >12 Hours per Week 45 50 55 60 65 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand Percent Survey Period Percentage of Patients Dialysing >12 Hours per Week

Patient Survival Years 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years 1997-1999 (2726) 2000-2002 (3220) 2003-2005 (3821) 2006-2007 (2975) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia

Patient Survival Years Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years 1997-1999 (352) 2000-2002 (582) 2003-2005 (666) 2006-2007 (500)

Patient Survival Years 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years Non-diabetic (9279) Diabetic (3463) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia

Patient Survival Years 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years Non-diabetic (1227) Diabetic (873) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand

Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia 1.00 0.80 0.60 Patient Survival 0.40 <40 (1582) 40-59 (4162) 0.20 60-74 (4592) >=75 (2406) 0.00 1 2 3 4 5 Years

Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand 1.00 0.80 0.60 Patient Survival 0.40 <40 (343) 40-59 (914) 0.20 60-74 (693) >=75 (150) 0.00 1 2 3 4 5 Years

Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Patient Survival 1 2 3 4 5 Years 1997-1999 (2726) 2000-2002 (3220) 2003-2005 (3821) 2006-2007 (2975) Patient Survival - Haemodialysis at 90 Days Censored for Transplant - Australia Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions

Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions Patient Survival - Haemodialysis at 90 Days Censored for Transplant - New Zealand 1.00 Adjusted for Age, Diabetic PRD, Race, Gender and Comorbid Conditions 0.90 0.80 Patient Survival 0.70 0.60 1997-1999 (352) 2000-2002 (582) 0.50 2003-2005 (666) 2006-2007 (500) 0.40 1 2 3 4 5 Years

Haemodialysis Surface Area Number of Patients Australia  13 103 203 1295 1 4 1423 1950 213 6 1105 115 729 8 100 130 1222 0 0 1348 2324 135 4 1494 117 652

Haemodialysis Surface Area New Zealand Number of Patients  3 28 20 3 0 0 192 455 1 2 294 1 208 4 14 22 3 0 0 173 454 0 1 525 0 227

Mean Haemoglobin Among Dialysis Patients 100 105 110 115 120 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand PD HD Mean Hb(g/L) Survey Period Mean Haemoglobin Among Dialysis Patients By Survey Period

Use of Erythropoietic Agents 30 40 50 60 70 80 90 100 Sep 02 Mar 03 Sep 03 Mar 04 Dec 04 Dec 05 Dec 06 Dec 07 Australia Use of Erythropoietic Agents By Survey Period New Zealand Percent Survey Period PD HD

Haemoglobin - Australia December 2005-2007 100 4 9 7 8 7 10 10 Hb (g/L) 11 14 15 16 15 80 23 140+ 21 23 26 25 26 60 130-139 Percent 28 27 120-129 26 25 40 21 25 110-119 20 34 35 27 28 26 28 <110 2005 2006 2007 2005 2006 2007 PD HD

Haemoglobin – New Zealand December 2005-2007 100 6 6 4 6 6 4 9 Hb (g/L) 10 11 12 12 13 80 19 22 140+ 20 22 21 21 60 130-139 Percent 31 25 22 25 25 23 120-129 40 110-119 20 38 39 39 34 36 37 <110 2005 2006 2007 2005 2006 2007 PD HD

Haemoglobin - Australia By Coronary Artery Disease Status December 2005-2007 100 35 35 80 44 Hb (g/L) 46 46 43 60 >120 Percent 30 31 28 29 110-120 40 27 27 <110 20 35 34 27 28 27 27 2005 2006 2007 2005 2006 2007 No CAD CAD

Haemoglobin – New Zealand By Coronary Artery Disease Status December 2005-2007 100 32 35 33 36 36 80 40 Hb (g/L) 60 >120 Percent 23 28 26 32 28 26 110-120 40 <110 41 20 38 40 36 33 36 2005 2006 2007 2005 2006 2007 No CAD CAD

Excludes hospitals with <10 patients Haemoglobin in Haemodialysis Patients Australia 31 December 2007 140 130 120 Median Hb (g/L) 110 100 Excludes hospitals with <10 patients 90 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients Haemoglobin in Haemodialysis Patients New Zealand 31 December 2007 140 130 120 Median Hb (g/L) 110 100 Excludes hospitals with <10 patients 90 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Haemodialysis Patients with Hb 110-129 g/L Australia 31 December 2007

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Haemodialysis Patients with Hb 110-129 g/L New Zealand 31 December 2007

Excludes hospitals with <10 patients 90 100 110 120 130 140 Median Hb (g/L) 5 10 15 20 25 30 35 Caring Hospital Haemoglobin in Peritoneal Dialysis Patients Australia 31 December 2007

Excludes hospitals with <10 patients 90 100 110 120 130 140 Median Hb (g/L) 1 2 3 4 5 6 7 8 9 10 Caring Hospital Haemoglobin in Peritoneal Dialysis Patients New Zealand 31 December 2007

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 % Peritoneal Dialysis Patients with Hb 110-129 g/L Australia 31 December 2007 35 Caring Hospital

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Peritoneal Dialysis Patients with Hb 110-129 g/L New Zealand 31 December 2007

Ferritin - Australia December 2005-2007 100 15 14 11 15 17 18 mcg/L 16 80 18 19 23 800+ 23 21 60 500-799 Percent 39 35 37 38 38 38 200-499 40 100-199 16 19 18 20 12 11 12 <100 16 13 15 12 11 11 2005 2006 2007 2005 2006 2007 PD HD

Ferritin - New Zealand December 2005-2007 100 12 11 10 15 15 mcg/L 20 14 18 80 18 21 22 800+ 22 60 500-799 42 Percent 39 40 36 36 31 200-499 40 100-199 18 21 17 15 14 12 20 <100 14 12 14 13 13 15 2005 2006 2007 2005 2006 2007 PD HD

Transferrin Saturation - Australia December 2005-2007 100 13 12 13 14 14 15 Tsat (%) 80 20 20 21 20 19 19 40+ 60 Percent 30-39 41 38 38 37 41 39 40 20-29 20 <20 26 27 27 29 29 30 2005 2006 2007 2005 2006 2007 PD HD

Transferrin Saturation - New Zealand December 2005-2007 100 16 14 13 15 13 15 Tsat (%) 80 19 22 22 19 21 19 40+ 60 Percent 30-39 37 36 33 39 38 38 40 20-29 20 <20 29 30 33 26 26 26 2005 2006 2007 2005 2006 2007 PD HD

Excludes hospitals with <10 patients % Haemodialysis Patients with Ferritin 200-500 mcg/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with Ferritin 200-500 mcg/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Ferritin 200-500 mcg/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Ferritin 200-500 mcg/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with TSat >20% Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with TSat >20% New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with TSat >20% Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with TSat >20% New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

Serum Calcium - Australia December 2005-2007 100 8 6 8 Calcium 12 11 9 (mmol/L) 21 22 80 25 27 28 29 >=2.6 60 38 2.4-2.5 Percent 37 41 40 36 37 40 2.2-2.3 2.0-2.1 22 26 20 18 19 20 17 <2.0 11 7 9 5 5 6 2005 2006 2007 2005 2006 2007 PD HD

Serum Calcium - New Zealand December 2005-2007 100 Calcium 12 10 11 14 14 20 (mmol/L) 80 28 25 30 35 33 >=2.6 36 60 2.4-2.5 Percent 36 37 34 40 2.2-2.3 31 33 27 2.0-2.1 20 22 19 20 15 13 16 <2.0 5 5 5 4 6 4 2005 2006 2007 2005 2006 2007 PD HD

Excludes hospitals with <10 patients % Haemodialysis Patients with Calcium 2.1-2.4 mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with Calcium 2.1-2.4 mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Calcium 2.1-2.4 mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Calcium 2.1-2.4 mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

Serum Phosphate - Australia December 2005-2007 100 Phosphate 35 38 37 36 39 38 (mmol/L) 80 >=1.8 60 15 13 15 14 14 Percent 15 1.6-1.7 17 15 16 40 18 15 16 1.4-1.5 20 33 34 35 29 30 32 <1.4 2005 2006 2007 2005 2006 2007 PD HD

Serum Phosphate - New Zealand December 2005-2007 100 Phosphate 40 40 (mmol/L) 80 44 48 54 54 >=1.8 60 Percent 14 16 15 1.6-1.7 16 40 13 13 20 15 17 12 1.4-1.5 11 13 20 29 <1.4 24 26 25 21 21 2005 2006 2007 2005 2006 2007 PD HD

Excludes hospitals with <10 patients % Haemodialysis Patients with Phosphate 0.8-1.6 mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with Phosphate 0.8-1.6 mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Phosphate 0.8-1.6 mmol/L Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Phosphate 0.8-1.6 mmol/L New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

Calcium Phosphate Product - Australia December 2005-2007 100 Ca X P 18 16 16 20 20 17 (mmol2/L2) 80 9 10 11 9 11 10 >=5.0 13 14 13 12 13 13 60 4.5-4.9 Percent 17 15 16 17 14 15 40 4.0-4.4 3.5-3.9 43 43 46 42 43 42 20 <3.5 2005 2006 2007 2005 2006 2007 PD HD

Calcium Phosphate Product - New Zealand December 2005-2007 100 Ca X P 20 18 24 (mmol2/L2) 30 35 33 80 11 12 11 >=5.0 14 11 14 13 60 12 12 4.5-4.9 Percent 14 16 17 14 13 18 40 14 4.0-4.4 13 13 3.5-3.9 20 39 40 35 32 27 28 <3.5 2005 2006 2007 2005 2006 2007 PD HD

Excludes hospitals with <10 patients % Haemodialysis Patients with Ca-P Product <4.0 mmol2/L2 Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 45 50 55 60 Caring Hospital

Excludes hospitals with <10 patients % Haemodialysis Patients with Ca-P Product <4.0 mmol2/L2 New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Ca-P Product <4.0 mmol2/L2 Australia 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 Caring Hospital

Excludes hospitals with <10 patients % Peritoneal Dialysis Patients with Ca-P Product <4.0 mmol2/L2 New Zealand 31 December 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 8 9 10 Caring Hospital

HD Three Sessions per Week Urea Reduction Ratio HD Three Sessions per Week 100 URR (%) 12 11 12 22 24 28 13 80 16 17 80-100 75-79 27 26 23 22 60 27 25 Percent 70-74 20 40 26 22 26 21 65-69 25 18 16 60-64 20 15 14 14 12 6 6 12 14 5 12 <60 4 3 3 2005 2006 2007 2005 2006 2007 Australia New Zealand

Urea Reduction Ratio Related to Type of Access HD Three Sessions per Week December 2007 100 URR (%) 12 10 21 21 26 12 80-100 80 43 18 20 19 19 75-79 60 28 22 Percent 70-74 22 26 22 26 40 23 65-69 27 18 13 19 17 60-64 20 15 11 12 11 10 17 5 10 9 <60 8 3 3 1 AVF AVG CVC AVF AVG CVC Australia New Zealand

Excludes hospitals with <10 patients 60 70 80 90 100 Median URR (%) 5 10 15 20 25 30 35 40 45 50 55 Caring Hospital URR (%) – Haemodialysis Patients (Three Sessions per Week) Australia 31 December 2007

Excludes hospitals with <10 patients 60 70 80 90 100 Median URR (%) 1 2 3 4 5 6 7 Caring Hospital URR (%) - Haemodialysis Patients (Three Sessions per Week) New Zealand 31 December 2007

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Haemodialysis Patients with URR >70% (Three Sessions per Week) Australia 31 December 2007

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 Caring Hospital % Haemodialysis Patients with URR >70% (Three Sessions per Week) New Zealand 31 December 2007

Vascular Access - Initial RRT Haemodialysis at Initial Modality AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 25 25 25 22 80 40 46 45 50 60 36 37 37 37 Percent 28 27 40 3 3 3 30 2 27 1 1 2 2 20 36 35 36 37 31 27 22 23 2004 2005 2006 2007 2004 2005 2006 2007 Australia New Zealand

Vascular Access - Initial RRT 24 2 44 29 35 37 25 38 4 21 3 39 20 8 54 28 1 31 40 23 47 13 7 30 50 60 80 100 Percent Australia New Zealand <25 25-54 55-74 >=75 Vascular Access - Initial RRT By Age Group 2007 AVF AVG Tunnel Catheter Non-Tunnel Catheter

Vascular Access - Initial RRT 38 3 35 25 2 36 24 37 23 41 21 34 26 32 40 27 20 60 80 100 Percent Non Diabetic Diabetic 2004 2005 2006 2007 Vascular Access - Initial RRT By Diabetic Status - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter

Vascular Access - Initial RRT 37 26 32 2 41 21 25 52 3 28 44 24 30 50 22 1 47 20 46 40 60 80 100 Percent Non Diabetic Diabetic 2004 2005 2006 2007 Vascular Access - Initial RRT By Diabetic Status - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter

Vascular Access - Initial RRT By Gender - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 25 22 23 23 24 23 28 28 80 60 40 35 36 35 36 39 Percent 37 39 1 40 1 2 2 4 5 5 3 20 40 39 39 39 33 29 29 32 2004 2005 2006 2007 2004 2005 2006 2007 Female Male

Vascular Access - Initial RRT By Gender - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 37 80 47 46 45 43 50 47 49 60 Percent 26 24 29 40 32 32 31 1 26 30 1 1 1 2 1 20 2 4 37 30 24 26 19 20 18 17 2004 2005 2006 2007 2004 2005 2006 2007 Female Male

Vascular Access - Initial RRT By Referral Time - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 18 19 18 16 80 41 42 42 39 30 31 33 31 60 Percent 3 3 4 3 40 47 49 51 54 49 45 47 48 20 2 1 1 10 9 6 7 2004 2005 2006 2007 2004 2005 2006 2007 Early Late

Vascular Access - Initial RRT By Referral - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 34 36 39 37 80 56 65 71 74 60 Percent 25 27 30 31 40 2 1 2 3 35 26 20 39 36 30 29 28 21 1 9 1 8 1 4 2004 2005 2006 2007 2004 2005 2006 2007 Early Late

Excludes hospitals with <10 patients % New HD Patients Starting with AVF/AVG Australia 1 Jan 2007 - 31 Dec 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 5 10 15 20 25 30 35 40 Caring Hospital

Excludes hospitals with <10 patients % New HD Patients Starting with AVF/AVG New Zealand 1 Jan 2007 - 31 Dec 2007 100 90 80 70 60 Percent 50 40 30 20 10 Excludes hospitals with <10 patients 1 2 3 4 5 6 7 Caring Hospital

Prevalent Haemodialysis Access AVF AVG Tunnel Catheter Non-Tunnel Catheter 1 1 1 2 3 2 1 100 10 11 11 13 25 22 23 24 14 12 11 11 80 6 5 6 7 60 Percent 40 75 76 76 76 69 70 70 66 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Australia New Zealand

Prevalent Haemodialysis Access By Age Group - December 2007 AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 1 1 1 1 2 12 13 15 18 19 28 26 8 31 2 12 80 12 6 5 5 6 Percent 60 40 79 79 75 73 75 67 67 61 20 <25 25-54 55-74 >=75 <25 25-54 55-74 >=75 Australia New Zealand

Prevalent Haemodialysis Access By Diabetic Status - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 1 1 1 1 1 1 1 100 9 9 10 12 13 13 14 15 15 13 13 11 11 10 80 13 10 60 Percent 40 75 77 77 77 73 75 76 74 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Non Diabetic Diabetic

Prevalent Haemodialysis Access By Diabetic Status - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 2 3 2 1 3 3 2 1 22 20 22 22 25 25 27 28 80 7 6 5 6 4 6 5 6 60 Percent 40 68 71 71 72 70 67 63 66 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Non Diabetic Diabetic

Prevalent Haemodialysis Access By Gender - Australia AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 1 1 1 1 1 1 1 9 9 10 13 11 14 14 17 10 9 8 8 80 20 18 16 15 60 Percent 82 81 81 40 80 66 67 69 68 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Female Male

Prevalent Haemodialysis Access By Gender - New Zealand AVF AVG Tunnel Catheter Non-Tunnel Catheter 100 2 4 2 1 3 2 2 1 20 18 18 19 34 29 31 32 80 3 2 3 4 11 8 9 60 11 Percent 40 78 74 77 77 56 58 58 53 20 Dec 04 Dec 05 Dec 06 Dec 07 Dec 04 Dec 05 Dec 06 Dec 07 Female Male

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 5 15 25 35 45 55 Caring Hospital % Prevalent HD Patients Dialysing with AVF/AVG Australia 31 December 2007

Excludes hospitals with <10 patients 10 20 30 40 50 60 70 80 90 100 Percent 1 2 3 4 5 6 7 8 9 Caring Hospital % Prevalent HD Patients Dialysing with AVF/AVG New Zealand 31 December 2007